// App-Quantinova.ai

e15068 : Impact of comorbidity on immune checkpoint blockade tolerance across tumor types.

Researchers

Presenter

  • Sean Clark-Garvey

Principal Investigators

  • Thomas Holden

  • Daniel S. Altman

  • Sheel A. Patel

  • Sharon Li

  • Reetu Mukherji

  • Philip Margiotta

  • Mario Caldararo

  • Marlana M. Orloff

  • Jennifer Maria Johnson

  • Ryan Michael Weight

Medical Centers

  • Thomas Jefferson University, Philadelphia, PA

  • Jefferson Medcl Coll, Bethesda, MD

  • Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA

  • Thomas Jefferson University Department of Dermatology, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Atezolizumab

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved